Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-318114

Director acquired 8,138 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jerman Michael Allen · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-23 Grant or award : show line 1 in the form +8,138 $1.92 $15,625 23,759 D
Loading xslF345X06/ownership.xml…